Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) [Phase 2]
Phase 2 safety and efficacy study of Tulisokibart (MK-7240/PRA023) in moderately to severely active ulcerative colitis completed, with resul…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: PRognOstiC valuE of rEd Density in Ulcerative Colitis
This update summarizes a completed clinical trial evaluating whether red density can prognosticate outcomes in ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis
The Belgian SMART trial evaluating golimumab for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny [NA]
A completed KU Leuven study evaluated whether home-based fecal calprotectin measurements can predict the induction outcome of adalimumab in …
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
A real-world, post-authorization safety study evaluating the safety of tofacitinib in adults with moderately to severely active ulcerative c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) [Phase 3]
Safety extension results from a Phase 3 trial of ontamalimab in moderate to severe Crohn's disease or ulcerative colitis have been completed…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Mitochondrial DAMPs as Mechanistic Biomarkers of Mucosal Inflammation in Crohn's Disease and Ulcerative Colitis
This clinical trial investigates mitochondrial DAMPs as mechanistic biomarkers of mucosal inflammation in Crohn's disease and ulcerative col…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)
Completed comparative effectiveness trial comparing biologics and small-molecule therapies for Crohn's disease and ulcerative colitis, with …
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission [NA]
This update reports a terminated clinical trial comparing trough-level–based spacing to clinically based spacing of infliximab infusions in …
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases
Clinical trial SAPHIR assesses predictive factors for persistence of adalimumab treatment after switching from reference product to Freseniu…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study) [NA]
A completed clinical trial (CUDISIA) evaluating artificial intelligence–assisted detection of dysplasia in patients with ulcerative colitis.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Research on the Mechanisms of Treatment Non-response in Inflammatory Bowel Disease Based on Multi-omics Technology
A clinical trial studying the mechanisms of non-response to treatment in inflammatory bowel disease using multi-omics approaches; the study …
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: MS-20 on Patients With Ulcerative Colitis(UC) [NA]
MS-20 is being evaluated in patients with Ulcerative Colitis and the trial is currently recruiting.
-
FDA approval · 2024-06-05FDA Approved: ZEPOSIA 7-DAY STARTER PACK — Supplemental Application (Celgene Corporation)
The FDA approved a supplemental application to authorize a Zeposia 7-day starter pack (ozanimod hydrochloride) from Celgene Corporation.
-
FDA approval · 2024-06-05FDA Approved: VELSIPITY — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental application for VELSIPITY (etrasimod), resulting in updated labeling and/or indication for ulcerative col…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
A completed real-world observational study evaluating vedolizumab and anti-TNF therapies in patients with ulcerative colitis or Crohn's dise…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Combination of Diet and Oral Budesonide for Ulcerative Colitis [NA]
Recruitment is ongoing for a study evaluating the combination of dietary modification with oral budesonide for Ulcerative Colitis, including…
-
FDA approval · 2024-05-23FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Mesalamine submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating the effects and mechanism of Baitouweng Decoction for ulcerative colitis (large intestine damp-heat syndro…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: The PRognostic Effect of Environmental Factors in Crohn's and Colitis
This clinical trial evaluated the prognostic impact of environmental factors on inflammatory bowel diseases, specifically Crohn's disease an…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
This update examines the role of CD4+ T cell subsets in Vedolizumab’s mechanism of action in ulcerative colitis.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Inflammatory Bowel Diseases Remission Registry
A registry study update for the Inflammatory Bowel Diseases Remission Registry, currently recruiting to collect data on Crohn's disease, ulc…
-
FDA approval · 2024-05-14FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) from Pfizer, granting an additional regulatory action under NDA 213082.
-
FDA approval · 2024-05-14FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for XELJANZ XR (tofacitinib) from Pfizer, introducing the extended-release formulation. Submission s…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis [Phase 1]
A Phase 1 clinical trial in active ulcerative colitis is evaluating fecal microbiota transplantation (FMT) and is currently recruiting.